MedTrace Logo

PRESERVE-Zenith® Branch Endovascular Graft-Iliac Bifurcation Clinical Study

NCT02571907 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2025-07-16

Study results available
· View outcomes & findings →

Summary

The purpose of this extended study is to evaluate the safety and effectiveness of the Zenith® Branch Endovascular Graft-Iliac Bifurcation in combination with the commercially available Atrium iCAST™ covered stent in patients in a treatment of aortoiliac and iliac aneurysms.

Conditions

  • Aortoiliac Aneurysms
  • Iliac Aneurysms

Interventions

DEVICE

Zenith® Branch Endovascular Graft-Iliac Bifurcation,

Implantation of the Zenith® Branch Endovascular Graft-Iliac Bifurcation.

DEVICE

Atrium iCAST™

Implantation of Atrium iCAST

DEVICE

Zenith® Flex AAA Endovascular Graft

Implantation of the Zenith Flex Endovascular Graft

Sponsors & Collaborators

  • Cook Research Incorporated

    lead INDUSTRY

Principal Investigators

  • W. Anthony Lee, MD FACS · Christine E. Lynn Heart and Vascular Institute

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-04-01
Primary Completion
2015-11-30
Completion
2020-11-04
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02571907 on ClinicalTrials.gov